%0 Journal Article
%T From bench to bedside: Platelet biomimetic nanoparticles as a promising carriers for personalized drug delivery.
%A Safdar A
%A Wang P
%A Muhaymin A
%A Nie G
%A Li S
%J J Control Release
%V 373
%N 0
%D 2024 Jul 13
%M 38977134
%F 11.467
%R 10.1016/j.jconrel.2024.07.013
%X In recent decades, there has been a burgeoning interest in cell membrane coating strategies as innovative approach for targeted delivery systems in biomedical applications. Platelet membrane-coated nanoparticles (PNPs), in particular, are gaining interest as a new route for targeted therapy due to their advantages over conventional drug therapies. Their stepwise approach blends the capabilities of the natural platelet membrane (PM) with the adaptable nature of manufactured nanomaterials, resulting in a synergistic combination that enhances drug delivery and enables the development of innovative therapeutics. In this context, we present an overview of the latest advancements in designing PNPs with various structures tailored for precise drug delivery. Initially, we describe the types, preparation methods, delivery mechanisms, and specific advantages of PNPs. Next, we focus on three critical applications of PNPs in diseases: vascular disease therapy, cancer treatment, and management of infectious diseases. This review presents our knowledge of PNPs, summarizes their advancements in targeted therapies and discusses the promising potential for clinical translation of PNPs.